Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.

The rtPA-associated aICH increased the risk of morbidity and mortality outcomes. Further treatment consensus, guideline generation, or clinical trials focusing on the treatment of rtPA-associated aICH may be required.